- Home
- PHH vs OPK Comparison
PHH vs OPK Comparison
Compare PHH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- OPK
- Stock Information
- Founded
- PHH 2016
- OPK 2007
- Country
- PHH China
- OPK United States
- Employees
- PHH N/A
- OPK N/A
- Industry
- PHH Package Goods/Cosmetics
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- PHH Consumer Discretionary
- OPK Health Care
- Exchange
- PHH Nasdaq
- OPK Nasdaq
- Market Cap
- PHH 894.1M
- OPK 1.0B
- IPO Year
- PHH 2024
- OPK 1995
- Fundamental
- Price
- PHH $0.44
- OPK $1.35
- Analyst Decision
- PHH
- OPK Buy
- Analyst Count
- PHH 0
- OPK 4
- Target Price
- PHH N/A
- OPK $2.75
- AVG Volume (30 Days)
- PHH 808.6K
- OPK 2.0M
- Earning Date
- PHH 01-01-0001
- OPK 11-06-2025
- Dividend Yield
- PHH N/A
- OPK N/A
- EPS Growth
- PHH N/A
- OPK N/A
- EPS
- PHH N/A
- OPK N/A
- Revenue
- PHH $2,768,120.00
- OPK $664,029,000.00
- Revenue This Year
- PHH N/A
- OPK N/A
- Revenue Next Year
- PHH N/A
- OPK $0.84
- P/E Ratio
- PHH N/A
- OPK N/A
- Revenue Growth
- PHH 42.65
- OPK N/A
- 52 Week Low
- PHH $0.43
- OPK $1.11
- 52 Week High
- PHH $41.49
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- PHH 26.55
- OPK 47.95
- Support Level
- PHH $0.48
- OPK $1.34
- Resistance Level
- PHH $0.64
- OPK $1.39
- Average True Range (ATR)
- PHH 0.05
- OPK 0.04
- MACD
- PHH 0.40
- OPK -0.00
- Stochastic Oscillator
- PHH 4.35
- OPK 11.11
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.